Steve Satek, Great Lakes Clinical Trials President had the honor of providing the keynote address at Alzheimer's Association's 25th Annual Conference for Professionals held on Tuesday, October 18, 2016 in Peoria, IL. The presentation entitled, "What's New in Alzheimer's Research" was attended by over 200 health care professionals from throughout the Central Illinois region.
The conference was held in conjunction with a Family Caregiver Conference, and highlighted by a special appreciation dinner for the family members and caregivers of patients suffering with Alzheimer's disease. The event also featured an exhibit hall of various Alzheimer's disease providers from throughout Illinois.
"Our organization, Great Lakes Clinical Trials, and the Alzheimer's Association are well aligned with the vision of a world without Alzheimer's disease," comments Mr. Satek. "The only way we will ever have new and better medications to prevent, cure or slow down the disease is through the clinical trial process. It is important to keep all healthcare professionals apprised of the developments in Alzheimer's research in order to properly educate patients of all types of care options, including research trials."
There is currently real hope for preventing or stopping the progression of memory loss. There have been significant new medical advances in the development of treatments which target the source of memory loss and Alzheimer's disease. The currently available prescription medications, over-the-counter remedies, and other therapies are only temporary, "band-aid" approaches that do not work for all people.
"The Alzheimer's Association is the nation's leading source of research funding for Alzheimer's disease," added Mr. Satek. "I am proud to work alongside this group and as a member of the Greater Illinois Chapter Medical and Scientific Advisory Committee. They have made significant strides in terms of educating the public of research opportunities, notably through their TrialMatch program.